Page 2 - Tom Lemberg News Today

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named veteran healthcare software development leader Alan Sun as...

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, today announced an upgraded universal mobile app for trial...

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named human resources management veteran Andi Seymour as its VP...

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Portamedic, which provides mobile examination and mobile...

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, today announced the appointment of Scott Garcia as vice president of...

Device delivers currents to the brain to restore activity usually lowered in depression patients - News - PharmaTimes

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Flow Neuroscience, creator of Europes only medically approved...

/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has named Lars-Olof "Lollo" Eriksson to its Advisory Board. Eriksson...

Curebase is a provider of decentralized clinical research software solutions and services to patients and medical providers. Founded by Tom Lemberg in 2017, Curebase is backed by investors that include GGV Capital, StartX (Stanford-StartX Fund), Y Combinator, Xfund, Bold Capital Partners and is headquartered in San Francisco.

The medical world has come a long way from the traditional, centralized way of conducting clinical trials, but there’s still a lot of modernization left to do. Curebase provides the infrastructure — physical and digital — for distributed clinical trials, and will be doubling down on its success with a new $40 million funding round. […]